BioSpace News Archive

The nation’s largest pure-play distributor of scientific products continues their strong growth through agreement with industry leader

– MARIO-3 Phase 2 study evaluating eganelisib added to standard of care Tecentriq ® and Abraxane ® regimen in frontline triple negative breast cancer (TNBC)–

Sunshine Biopharma Inc. today announced that it has received additional funding from RB Capital Partners, Inc. (“RB Capital”) in the amount of $900,000.

Sorrento Therapeutics (Nasdaq: SRNE) announced today that its partner Mabpharm Ltd (HK:2181) has received approval of its New Drug Application for its infliximab biobetter antibody in China.

Ascensia Diabetes Care, a global diabetes company, announced it has introduced a Patient Assistance Program in the United States to reduce out-of-pocket costs associated with the Eversense® Continuous Glucose Monitoring (CGM) System.

Stool management systems allow the patients to clear their rectums and some portions of their colon at regular intervals.

Ultrasonic energy was first used in the medical field for the treatment of Meniere’s disease in 1960.

Central venous catheter is a thin, flexible tube that is placed into the large vein above the heart, usually through a vein in the neck, chest, or arm.

Myovant Sciences, a healthcare company focused on redefining care for women and for men, announced the European Commission has approved the marketing authorization application for RYEQO® for the treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age, with no limitation for duration of use.

MONTREAL, July 20, 2021 /PRNewswire/ - NIMIUM Therapeutics, a Montreal-based biotech, has formed a partnership with Paraza Pharma to develop a new treatment for cardiometabolic diseases.